238 related articles for article (PubMed ID: 21168678)
21. YKL-40, a novel marker of cardiovascular complications, is related to kidney function in heart transplant recipients.
Przybyłowski P; Janik L; Wasilewski G; Nowak E; Koźlik P; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2860-3. PubMed ID: 25380936
[TBL] [Abstract][Full Text] [Related]
22. Estimation of glomerular filtration rate with creatinine-based versus cystatin C-based equations in kidney transplant recipients.
Savaj S; Shoushtarizadeh T; Abbasi MA; Razavimanesh SH; Ghods AJ
Iran J Kidney Dis; 2009 Oct; 3(4):234-8. PubMed ID: 19841528
[TBL] [Abstract][Full Text] [Related]
23. A possible role of hepcidin in the pathogenesis of anemia in heart allograft recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Jun; 42(5):1803-7. PubMed ID: 20620527
[TBL] [Abstract][Full Text] [Related]
24. Gender and renal function influence plasma levels of copeptin in healthy individuals.
Bhandari SS; Loke I; Davies JE; Squire IB; Struck J; Ng LL
Clin Sci (Lond); 2009 Feb; 116(3):257-63. PubMed ID: 18647134
[TBL] [Abstract][Full Text] [Related]
25. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Jun; 42(5):1797-802. PubMed ID: 20620526
[TBL] [Abstract][Full Text] [Related]
26. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
27. Chronic kidney disease in prevalent orthotopic heart transplant recipients using a new CKD-EPI formula.
Przybylowski P; Malyszko J; Malyszko J
Ann Transplant; 2010; 15(1):32-5. PubMed ID: 20305315
[TBL] [Abstract][Full Text] [Related]
28. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
29. Creatinine-based formulae for the estimation of glomerular filtration rate in heart transplant recipients.
Delanaye P; Nellessen E; Grosch S; Depas G; Cavalier E; Defraigne JO; Chapelle JP; Krzesinski JM; Lancellotti P
Clin Transplant; 2006; 20(5):596-603. PubMed ID: 16968485
[TBL] [Abstract][Full Text] [Related]
30. [Biomarkers of functional class in systolic heart failure: the relevance of copeptin].
Silva Marques J; Luz-Rodrigues H; David C; G Almeida A; Nunes Diogo A
Rev Port Cardiol; 2012 Nov; 31(11):701-10. PubMed ID: 23040871
[TBL] [Abstract][Full Text] [Related]
31. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
[TBL] [Abstract][Full Text] [Related]
32. Renalase and endothelial dysfunction in heart transplant recipients.
Przybylowski P; Koc-Zorawska E; Malyszko JS; Mysliwiec M; Malyszko J
Transplant Proc; 2013; 45(1):394-6. PubMed ID: 23375328
[TBL] [Abstract][Full Text] [Related]
33. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
[TBL] [Abstract][Full Text] [Related]
34. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
35. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
[TBL] [Abstract][Full Text] [Related]
36. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
Małyszko J; Małyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3069-72. PubMed ID: 19857679
[TBL] [Abstract][Full Text] [Related]
37. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.
Smilde TD; van Veldhuisen DJ; Navis G; Voors AA; Hillege HL
Circulation; 2006 Oct; 114(15):1572-80. PubMed ID: 17015793
[TBL] [Abstract][Full Text] [Related]
38. The correlation of renal allograft weight to metabolic index ratios and glomerular filtration rate among living-unrelated kidney transplant patients: a cross-sectional study.
Amante AJ; Piñon-Barretto SC
Transplant Proc; 2008 Sep; 40(7):2313-8. PubMed ID: 18790222
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
Li HX; Xu GB; Wang XJ; Zhang XC; Yang JM
Chin Med J (Engl); 2010 Mar; 123(6):745-51. PubMed ID: 20368098
[TBL] [Abstract][Full Text] [Related]
40. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
